Medicare At 50?
A new Senate bill would expand Medicare’s population. Under the bill, people aged 50-64 could buy into Medicare. The buy-in would be optional. Beneficiaries would be entitled to the same benefits, including access to Medicare Advantage (MA). Safeguards to stop offloading Medicaid recipients would exist.
#medicare #coverage
Payers Positive in Q3, Hospitals Mixed
Payers’ largely increased annual guidance during Q3 due to recovering finances, but for-profit hospitals were mixed. Tenet was a standout for performance.
#healthplans #hospitals #margins
KFF Outlook For Exchange Open Enrollment
Healthcare policy group KFF outlines what to expect in Exchange open enrollment:
- Double-digit hikes in premiums
- Most get subsidies
- Enrollment has fallen and may do so again
- More exits than entrants
#exchanges
https://www.kff.org/affordable-care-act/9-things-to-watch-for-the-2027-aca-open-enrollment-period/
KFF Outlines 340B Medicare Change
Healthcare policy group KFF covers the finalization of reduced drug payments to 340B qualified providers in Medicare. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction (CMS originally proposed reducing reimbursement to ASP minus 33.4%).
Medicare spending on 340B drugs will drop by an estimated $4.65 billion in 2027, while increasing spending on non-drug outpatient services by the same amount because of budget neutrality. Proposed cuts will reduce revenues among safety-net hospitals while increasing revenues among for-profit hospitals, among other differences. Safety-net hospitals will face a 5.2% net reduction of OPPS revenue under this proposal. For-profit hospitals will see a 6.8% net increase in OPPS revenues.
The budget neutrality shift creates an odd outcome, but the reform is not unreasonable. The 340B program is out of control and unaccountable.
#340b #drugpricing #hospitals
— Marc S. Ryan
